PTHS
Price
$32.20
Change
-$1.04 (-3.13%)
Updated
Sep 26, 01:09 PM (EDT)
Capitalization
101.76M
68 days until earnings call
SONN
Price
$5.05
Change
-$0.28 (-5.25%)
Updated
Sep 26, 01:28 PM (EDT)
Capitalization
36.39M
Interact to see
Advertisement

PTHS vs SONN

Header iconPTHS vs SONN Comparison
Open Charts PTHS vs SONNBanner chart's image
Pelthos Therapeutics
Price$32.20
Change-$1.04 (-3.13%)
Volume$200
Capitalization101.76M
Sonnet BioTherapeutics Holdings
Price$5.05
Change-$0.28 (-5.25%)
Volume$106
Capitalization36.39M
PTHS vs SONN Comparison Chart in %
Loading...
PTHS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PTHS vs. SONN commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTHS is a Hold and SONN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (PTHS: $33.24 vs. SONN: $5.33)
Brand notoriety: PTHS and SONN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PTHS: 49% vs. SONN: 103%
Market capitalization -- PTHS: $101.76M vs. SONN: $36.39M
PTHS [@Biotechnology] is valued at $101.76M. SONN’s [@Biotechnology] market capitalization is $36.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTHS’s FA Score shows that 0 FA rating(s) are green whileSONN’s FA Score has 0 green FA rating(s).

  • PTHS’s FA Score: 0 green, 5 red.
  • SONN’s FA Score: 0 green, 5 red.
According to our system of comparison, both PTHS and SONN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTHS’s TA Score shows that 3 TA indicator(s) are bullish while SONN’s TA Score has 6 bullish TA indicator(s).

  • PTHS’s TA Score: 3 bullish, 5 bearish.
  • SONN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SONN is a better buy in the short-term than PTHS.

Price Growth

PTHS (@Biotechnology) experienced а -0.21% price change this week, while SONN (@Biotechnology) price change was -29.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +9.02%, and the average quarterly price growth was +51.46%.

Reported Earning Dates

PTHS is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTHS($102M) has a higher market cap than SONN($36.4M). PTHS YTD gains are higher at: 418.565 vs. SONN (265.068). PTHS has higher annual earnings (EBITDA): -8.54M vs. SONN (-13.97M). SONN has more cash in the bank: 321K vs. PTHS (59.2K). SONN has less debt than PTHS: SONN (68.8K) vs PTHS (2.31M). SONN has higher revenues than PTHS: SONN (1M) vs PTHS (0).
PTHSSONNPTHS / SONN
Capitalization102M36.4M280%
EBITDA-8.54M-13.97M61%
Gain YTD418.565265.068158%
P/E RatioN/A0.29-
Revenue01M-
Total Cash59.2K321K18%
Total Debt2.31M68.8K3,350%
FUNDAMENTALS RATINGS
SONN: Fundamental Ratings
SONN
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PTHSSONN
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
PTHS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKHSF22.750.54
+2.43%
Sekisui House Ltd.
ASFT0.25N/A
N/A
AppSoft Technologies, Inc.
PHPRF1.24N/A
N/A
Primary Health Properties Plc.
BYLTF0.20N/A
N/A
Baylin Technologies Inc.
STBMF0.29N/A
N/A
St. Barbara Ltd.

PTHS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTHS has been closely correlated with SONN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if PTHS jumps, then SONN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTHS
1D Price
Change %
PTHS100%
-1.89%
SONN - PTHS
70%
Closely correlated
-14.17%
KLRS - PTHS
40%
Loosely correlated
+5.30%
LIXT - PTHS
34%
Loosely correlated
-1.69%
MBIO - PTHS
29%
Poorly correlated
-1.23%
CYBN - PTHS
27%
Poorly correlated
-2.98%
More

SONN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SONN has been closely correlated with PTHS. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SONN jumps, then PTHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
-14.17%
PTHS - SONN
70%
Closely correlated
-1.89%
PRME - SONN
28%
Poorly correlated
-6.12%
DWTX - SONN
27%
Poorly correlated
-0.78%
JSPR - SONN
26%
Poorly correlated
N/A
PHAR - SONN
25%
Poorly correlated
+0.53%
More